[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Form 144 notice shows a proposed sale of 250 Class A shares through Fidelity Brokerage Services (NYSE) on 10/01/2025, with an aggregate market value of $14,000. The shares are reported as acquired on 10/01/2025 via options granted 03/01/2023 and will be paid in cash.

The filing also lists seven prior Class A sales by Michael Y. Chi during July–September 2025 totaling $3,717,768.50 in gross proceeds. The filer affirms no undisclosed material adverse information and provides broker and sale dates but omits filer CIK and full contact details in the provided text.

Positive

• Required sale details disclosed: class, broker, number of shares, market value, exchange, and acquisition method are provided.
• Attestation included: signature representation asserts no undisclosed material adverse information, complying with Rule 144 requirements.

Negative

• Significant prior insider sales: Seven dispositions from July to September 2025 generated approximately $3,717,768.50 in gross proceeds, which may be material to some investors.
• Incomplete filer metadata in excerpt: filer CIK and contact details are not provided in the supplied content.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; prior sales raised material proceeds but the new planned sale is small.

The Form 144 documents a planned sale of 250 Class A shares valued at $14,000 and confirms acquisition via options exercised on the same date. The recent history shows multiple dispositions by Michael Y. Chi that generated roughly $3.72 million in gross proceeds across seven transactions from July to September 2025. For investors, concentrated insider selling over a short period is a datapoint to monitor but the current notice itself is a routine regulatory disclosure under Rule 144.

Compliance Officer

TL;DR: Form appears to follow Rule 144 disclosure format but some filer identifiers are not present in the excerpt.

The notice includes required sale details: class, broker, amount, market value, acquisition details, and a signature representation about material non-public information. The filing lists the broker and sale schedule and details option grant and cash payment. However, the provided content lacks explicit filer CIK and submission contact fields, which are normally present elsewhere in a complete filing; the excerpt does include the mandatory attestation language.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	250	14000.00	217641958	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	10/01/2025	Options Granted - 03/01/2023	Issuer			250	10/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/23/2025	13750	770000.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/24/2025	2100	120792.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/31/2025	26350	1765450.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/01/2025	250	16110.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/15/2025	4150	232400.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/17/2025	13749	694324.50
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/24/2025	2100	118692.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the HIMS Form 144 announce?

The notice reports a proposed sale of 250 Class A shares via Fidelity on 10/01/2025 with aggregate market value of $14,000.

Who is the seller named in the filing?

The prior sales listed in the filing were made by Michael Y. Chi at the address shown; the 10/01/2025 proposed sale is reported for the same person.

How many shares and proceeds were sold in the past three months?

Seven transactions from July–September 2025 are listed, totaling $3,717,768.50 in gross proceeds.

How were the shares being offered acquired?

The 250 shares to be sold were reported as acquired on 10/01/2025 via options granted 03/01/2023, with payment listed as cash.

Which broker will handle the proposed sale?

The broker named is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

Does the filing include the mandatory attestation about material non-public information?

Yes. The person for whose account the securities are to be sold attests they do not know any material adverse information that has not been publicly disclosed.